HORIZON | siNPAIN meeting in Barcelona

The objective of this project is to create a siRNA-combined advanced therapy, which will allow a more personalised treatment for different stages of osteoarthritis. All siNPAIN partners are working hard to develop efficient therapy to improve the quality of life of those affected by osteoarthritis, a chronic joint condition that affects more and more people every year.

The objective of this project is to create a siRNA-combined advanced therapy, which will allow a more personalised treatment for different stages of osteoarthritis. All siNPAIN partners are working hard to develop efficient therapy to improve the quality of life of those affected by osteoarthritis, a chronic joint condition that affects more and more people every year.
November 22, 2023

The EU-funded HORIZON project siNPAIN has held its third progress meeting in Barcelona, on this occasion hosted by Asphalion.

Asphalion, as regulatory partner, presented the finalized roadmap and shared the information needed for the preparation of the ITF document. Also, our experts Joan Cabellos and Núria Coderch carried out a regulatory workshop. The rest of partners recapped on their advances so far and talked about future plans.

In addition to this, we had the pleasure to have Dr Josep Vergés talk about the Osteoarthritis Foundation International (OAFI) he presides. He explained about the first and only foundation exclusively dedicated to people with osteoarthritis (OA) worldwide, their mission on promoting the prevention and treatment of musculoskeletal diseases and the activities they carry out, among many other things.

Thanks to the partners for your support throughout the whole event and looking forward to the next meeting already!

For further information, you can also contact us at: [email protected]

Search News & Events

  • Filter by category

Share

Related news and events

HORIZON EUROPE | NABIHEAL progress meeting

Two years into the NABIHEAL project, Asphalion experts Marta Rayo Lunar and Sergio Veiga attended the consortium meeting in Zagreb, hosted by IMI, to review

HORIZON EUROPE PROJECT | KeratOPrinter Kick-Off Meeting

Corneal blindness affects over 11.7 million people worldwide, yet only 1 in 70 patients receive a corneal transplant due to a severe donor shortage. The KeratOPrinter project aims to address this gap by developing a groundbreaking 4D bioprinting suite capable of producing fully functional, biocompatible human corneas. Combining expertise from world-class partners, the project focuses on scalable cell sources, advanced bioinks, high-precision bioprinting, clinical handling solutions, regulatory compliance, and a strong collaborative network. By 2035, KeratOPrinter seeks to revolutionize corneal transplantation and restore vision for millions.

For further information

If you are interested in our services, or wish to get in touch for a general enquiry, please contact us for more information.

Fill the form and we will contact you as soon as possible.

You can also follow us on:

Schedule a Free Meeting

Schedule here a free 30-minutes meeting with one of our consultants and tell us about your project, challenges or doubts. 

We will be happy to assist you!

Schedule a meeting